Study | Reference | Short description | Continent |
---|---|---|---|
I | Jie et al. [21] | CVD (n = 218) vs. controls (n = 186) | A |
II | Karlsson et al. [22] | CVD (n = 13) vs. controls (n = 12) | E |
III | Qin et al. [23] | T2D (n = 182) vs. controls (n = 185) | A |
IV | Forslund et al. [24] | T2D (n = 75), T1D (n = 31) vs. samples from VI | E |
V | Karlsson et al. [25] | T2D (n = 43) vs. controls (n = 53) | E |
VI | Le Chatelier et al. [26] | Obese (n = 161) vs. controls (n = 109) | E |
VII | Feng et al. [27] | CRC (n = 46), LA (n = 47) vs. controls (n = 63) | A/E |
VIII | Zeller et al. [28] | CRC (n = 91), LA (n = 15), SA (n = 27) vs. controls (n = 66) | E |
IX | Vogtmann et al. [29] | CRC (n = 52) vs. controls (n = 52) | NA |
X | Qin et al. [30] | Cirrhosis (n = 123) vs. controls (n = 114) | A |
XI | Qin et al. [31] | UC (n = 21), CD (n = 4) vs. controls (n = 14) | E |
XII | Schirmer et al. [32] | MTG: UC (n = 78), CD (n = 175) vs. controls (n = 55) | NA |
MTX: UC (n = 46), CD (n = 121) vs. controls (n = 11) | |||
XIII | Mehta et al. [53] | MTG and MTX of 78 subjects (4 time points) | NA |